ERS statement on transition of care in childhood interstitial
lung diseases

J 2024

ERS statement on transition of care in childhood interstitial lung diseases

POHUNEK, Petr; Effrosyni MANALI; Susanne VIJVERBERG; Julia CARLENS; Felix CHUA et al.

Základní údaje

Originální název

ERS statement on transition of care in childhood interstitial lung diseases

Autoři

Vydání

European Respiratory Journal, Sheffield, European Respiratory Society Journals Ltd. 2024, 0903-1936

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30203 Respiratory systems

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

fulltext

Impakt faktor

Impact factor: 21.000

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14210/24:00136293

Organizační jednotka

Filozofická fakulta

Klíčová slova anglicky

adult care; paediatric care; ILD; transition of care; interstitial lung disease

Štítky

rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 4. 4. 2025 13:15, Mgr. et Mgr. Stanislav Hasil, Ph.D.

Anotace

V originále

Interstitial lung diseases (ILD) are a heterogeneous group of rare diffuse diseases affecting the lung parenchyma in children and adults. Childhood interstitial lung diseases (chILD) are often diagnosed at very young age, affect the developing lung, and can have different presentations and prognosis compared to adult forms of these diseases. In addition, chILD in many cases may apparently remit, and have a better response to therapy and better prognosis than adult ILD. Many affected children will reach adulthood with minimal activity or clinical remission of the disease. They need continuing care and follow-up from childhood to adulthood if the disease persists and progresses over time, but also if they are asymptomatic and in full remission. Therefore, for every chILD patient an active transition process from paediatric to adult care should be guaranteed. This European Respiratory Society (ERS) statement provides a review of the literature and current practice concerning transition of care in chILD. It draws on work in existing transition care programmes in other chronic respiratory diseases, disease-overarching transition-of-care programmes, evidence on the impact of these programmes on clinical outcomes, current evidence regarding long-term remission of chILD as well as the lack of harmonisation between the current adult ILD and chILD classifications impacting on transition of care. While the transition system is well established in several chronic diseases, such as cystic fibrosis or diabetes mellitus, we could not find sufficient published evidence on transition systems in chILD. This statement summarises current knowledge, but cannot yet provide evidence-based recommendations for clinical practice.

Citovat

POHUNEK, Petr; Effrosyni MANALI; Susanne VIJVERBERG; Julia CARLENS; Felix CHUA; Ralph EPAUD; Carlee GILBERT; Matthias GRIESE; Bulent KARADAG; Eitan KEREM; Vaclav KOUCKY; Nadia NATHAN; Spyridon PAPIRIS; Suzanne TERHEGGEN-LAGRO; Lukáš PLCH; Alba Torrent VERNETTA a Andrew BUSH. ERS statement on transition of care in childhood interstitial lung diseases. European Respiratory Journal. Sheffield: European Respiratory Society Journals Ltd., 2024, roč. 64, č. 2, s. 1-19. ISSN 0903-1936. Dostupné z: https://doi.org/10.1183/13993003.02160-2023.

@article{2412917,
   author = {Pohunek, Petr and Manali, Effrosyni and Vijverberg, Susanne and Carlens, Julia and Chua, Felix and Epaud, Ralph and Gilbert, Carlee and Griese, Matthias and Karadag, Bulent and Kerem, Eitan and Koucky, Vaclav and Nathan, Nadia and Papiris, Spyridon and TerheggenandLagro, Suzanne and Plch, Lukáš and Vernetta, Alba Torrent and Bush, Andrew},
   article_location = {Sheffield},
   article_number = {2},
   doi = {https://doi.org/10.1183/13993003.02160-2023},
   keywords = {adult care; paediatric care; ILD; transition of care; interstitial lung disease},
   language = {eng},
   issn = {0903-1936},
   journal = {European Respiratory Journal},
   title = {ERS statement on transition of care in childhood interstitial lung diseases},
   url = {https://erj.ersjournals.com/content/early/2024/05/23/13993003.02160-2023},
   volume = {64},
   year = {2024}
}

TY  - JOUR
ID  - 2412917
AU  - Pohunek, Petr - Manali, Effrosyni - Vijverberg, Susanne - Carlens, Julia - Chua, Felix - Epaud, Ralph - Gilbert, Carlee - Griese, Matthias - Karadag, Bulent - Kerem, Eitan - Koucky, Vaclav - Nathan, Nadia - Papiris, Spyridon - Terheggen-Lagro, Suzanne - Plch, Lukáš - Vernetta, Alba Torrent - Bush, Andrew
PY  - 2024
TI  - ERS statement on transition of care in childhood interstitial lung diseases
JF  - European Respiratory Journal
VL  - 64
IS  - 2
SP  - 1-19
EP  - 1-19
PB  - European Respiratory Society Journals Ltd.
SN  - 09031936
KW  - adult care
KW  - paediatric care
KW  - ILD
KW  - transition of care
KW  - interstitial lung disease
UR  - https://erj.ersjournals.com/content/early/2024/05/23/13993003.02160-2023
N2  - Interstitial lung diseases (ILD) are a heterogeneous group of rare diffuse diseases affecting the lung parenchyma in children and adults. Childhood interstitial lung diseases (chILD) are often diagnosed at very young age, affect the developing lung, and can have different presentations and prognosis compared to adult forms of these diseases. In addition, chILD in many cases may apparently remit, and have a better response to therapy and better prognosis than adult ILD. Many affected children will reach adulthood with minimal activity or clinical remission of the disease. They need continuing care and follow-up from childhood to adulthood if the disease persists and progresses over time, but also if they are asymptomatic and in full remission. Therefore, for every chILD patient an active transition process from paediatric to adult care should be guaranteed. This European Respiratory Society (ERS) statement provides a review of the literature and current practice concerning transition of care in chILD. It draws on work in existing transition care programmes in other chronic respiratory diseases, disease-overarching transition-of-care programmes, evidence on the impact of these programmes on clinical outcomes, current evidence regarding long-term remission of chILD as well as the lack of harmonisation between the current adult ILD and chILD classifications impacting on transition of care. While the transition system is well established in several chronic diseases, such as cystic fibrosis or diabetes mellitus, we could not find sufficient published evidence on transition systems in chILD. This statement summarises current knowledge, but cannot yet provide evidence-based recommendations for clinical practice.
ER  -

POHUNEK, Petr; Effrosyni MANALI; Susanne VIJVERBERG; Julia CARLENS; Felix CHUA; Ralph EPAUD; Carlee GILBERT; Matthias GRIESE; Bulent KARADAG; Eitan KEREM; Vaclav KOUCKY; Nadia NATHAN; Spyridon PAPIRIS; Suzanne TERHEGGEN-LAGRO; Lukáš PLCH; Alba Torrent VERNETTA a Andrew BUSH. ERS statement on transition of care in childhood interstitial lung diseases. \textit{European Respiratory Journal}. Sheffield: European Respiratory Society Journals Ltd., 2024, roč.~64, č.~2, s.~1-19. ISSN~0903-1936. Dostupné z: https://doi.org/10.1183/13993003.02160-2023.

Přehled o publikaci